BIOENGINEER.ORG

COLUMBUS, Ohio - Two immunotherapy drugs currently approved by the U.S. Food and Drug Administration (FDA) for the treatment of melanoma also show promise for...

PHILADELPHIA -- The American Association for Cancer Research (AACR) has published its first set of consensus screening recommendations for children with common cancer predisposition syndromes...

(Bethesda, MD, June 05, 2017) Rakesh Jain, PhD, Director of the Edwin L. Steele Laboratory for Tumor Biology at the Massachusetts General Hospital and supported...

Monica Morrow, M.D., of Memorial Sloan Kettering Cancer Center, New York, and coauthors investigated the impact of a 2014 consensus statement endorsing a minimal negative...

CATONSVILLE, MD, June 5, 2017 - Offering comprehensive health insurance plans with low deductibles and co-pay in exchange for higher annual premiums seems like a...

ASCO Perspective "It's been nearly 15 years since EGFR-targeted therapies were introduced, helping extend survival for thousands of patients in the time since. The second...

ASCO Perspective "While it's still early, these data are a strong sign that CAR T-cell therapy can send multiple myeloma into remission," said ASCO Expert...

ASCO Perspective "The fact that this second-generation targeted treatment halted advanced lung cancer growth for more than two years while preventing brain metastases is a...

ASCO Perspective "The introduction and success of HER2 targeted treatment was a turning point in breast cancer care. It's promising that some women in this...

ASCO Perspective "We're seeing a second wave of immunotherapy with expansion of its use in more cancer types. This study shows that immunotherapy may represent...

ASCO Perspective "A diagnosis of advanced cancer weighs heavily on patients and families, and this study gives a new approach that can ease this burden....

ASCO Perspective "When the doctor says cancer, it can bring on a wave of emotions, fear, and uncertainty. Cancer care and treatment must be paired...

ASCO Perspective "The number of people surviving cancer is higher than ever before, but many survivors fear that the cancer will return even long after...

ASCO Perspective "Spinal cord compression is a debilitating condition that many patients with advanced cancer experience. Until now, patients often had to spend multiple days...

ASCO Perspective "For men who are diagnosed with advanced prostate cancer, treatment has evolved into more effective approaches, first with chemotherapy and now with abiraterone,"...